A 28-year-old woman with newly diagnosed pulmonary tuberculosis is started on standard first-line therapy (RIPE: rifampicin, isoniazid, pyrazinamide, ethambutol). She is also on oral contraceptive pills (OCPs) for contraception. After 3 weeks of anti-tuberculous therapy, she reports breakthrough bleeding and is concerned about contraceptive failure. What is the mechanism of this drug interaction and what is the most appropriate counseling?

Explanation

## Drug Interaction: Rifampicin and Oral Contraceptive Pills ## Mechanism of Interaction **Key Point:** Rifampicin is a potent **inducer of hepatic cytochrome P450 enzymes** (particularly CYP3A4, CYP2C9, CYP2C19). This accelerates the metabolism of ethinyl estradiol and progestins, reducing their plasma concentrations and contraceptive efficacy. **High-Yield:** Breakthrough bleeding is a clinical sign of **subtherapeutic OCP levels** due to enzyme induction. The patient is at risk of contraceptive failure and unintended pregnancy. ## Pharmacokinetic Details ```mermaid flowchart LR A[Rifampicin]:::action --> B[Induces CYP3A4, CYP2C9, CYP2C19]:::outcome B --> C[Increased metabolism of ethinyl estradiol & progestins]:::outcome C --> D[Reduced OCP bioavailability]:::urgent D --> E[Breakthrough bleeding & contraceptive failure]:::urgent ``` ## Management Recommendations **Clinical Pearl:** The WHO and CDC recommend one of the following strategies during rifampicin-based TB treatment: | Strategy | Details | |----------|----------| | **Increase OCP dose** | Use pills with ≥50 µg ethinyl estradiol (standard pills have 20–35 µg) | | **Switch to alternative method** | Intrauterine device (IUD), implant, or injection (not affected by enzyme induction) | | **Dual contraception** | Continue OCP + barrier method (condom) during TB treatment | | **Duration of precaution** | Continue precautions for **4 weeks after completing rifampicin** (time for enzyme induction to reverse) | **Key Point:** Progestin-only pills (POPs, "mini-pill") are **not a reliable alternative** because they are also metabolized by P450 enzymes and have a narrow therapeutic margin. ## Why This Option is Correct Option 1 correctly identifies the mechanism (CYP450 induction) but incorrectly recommends switching to a progestin-only pill, which is equally affected by enzyme induction and is less reliable for contraception. **Option 1 is the single best answer** because it: 1. Correctly identifies rifampicin-induced CYP450 enzyme induction 2. Correctly identifies reduced OCP bioavailability as the cause 3. Recommends appropriate management: **increasing hormone content** OR switching to a non-hormonal method 4. Advises **barrier contraception during and 4 weeks after TB treatment** to cover the period of enzyme induction and its reversal [cite:WHO Consolidated TB Guidelines 2023; CDC Drug Interactions Handbook]